Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers Irigoyen Medina, Antonio Jiménez Luna, Cristina Benavides, Manuel Caba Pérez, Octavio Gallego, Javier Ortuño, Francisco M. Guillen-Ponce, Carmen Rojas Ruiz, Ignacio Aranda, Enrique Torres, Carolina Prados Salazar, José Carlos Applying differentially expressed genes (DEGs) to identify feasible biomarkers in diseases can be a hard task when working with heterogeneous datasets. Expression data are strongly influenced by technology, sample preparation processes, and/or labeling methods. The proliferation of different microarray platforms for measuring gene expression increases the need to develop models able to compare their results, especially when different technologies can lead to signal values that vary greatly. Integrative meta-analysis can significantly improve the reliability and robustness of DEG detection. The objective of this work was to develop an integrative approach for identifying potential cancer biomarkers by integrating gene expression data from two different platforms. Pancreatic ductal adenocarcinoma (PDAC), where there is an urgent need to find new biomarkers due its late diagnosis, is an ideal candidate for testing this technology. Expression data from two different datasets, namely Affymetrix and Illumina (18 and 36 PDAC patients, respectively), as well as from 18 healthy controls, was used for this study. A meta-analysis based on an empirical Bayesian methodology (ComBat) was then proposed to integrate these datasets. DEGs were finally identified from the integrated data by using the statistical programming language R. After our integrative meta-analysis, 5 genes were commonly identified within the individual analyses of the independent datasets. Also, 28 novel genes that were not reported by the individual analyses (`gained' genes) were also discovered. Several of these gained genes have been already related to other gastroenterological tumors. The proposed integrative metaanalysis has revealed novel DEGs that may play an important role in PDAC and could be potential biomarkers for diagnosing the disease. 2018-06-14T08:35:02Z 2018-06-14T08:35:02Z 2018-04-04 info:eu-repo/semantics/article Irigoyen A, Jimenez-Luna C, Benavides M, Caba O, Gallego J, Ortuño FM, et al. (2018) Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers. PLoS ONE 13(4): e0194844. [http://hdl.handle.net/10481/51463] http://hdl.handle.net/10481/51463 10.1371/journal.pone.0194844 eng http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess Atribución 3.0 España Public Library of Science (PLOS)